Skip to content

Clinical trials

Carcinoma, Lobular trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Lobular Country / region: United States Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20031
20043
20056
20082
20093
20104
20111
20121
20132
20142
20161
20181
20191
20201
20211
20221
20234
20245
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Recruiting10
Active, not recruiting7
Terminated5
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Memorial Sloan Kettering Cancer Center4
City of Hope Medical Center3
Dana-Farber Cancer Institute3
Intarcia Therapeutics3
Abramson Cancer Center at Penn Medicine2
Alliance for Clinical Trials in Oncology2
Rutgers, The State University of New Jersey2
University of California, Davis2
University of California, San Francisco2
American College of Radiology Imaging Network1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Lobular46
Breast Neoplasms33
Carcinoma, Ductal, Breast23
Carcinoma, Intraductal, Noninfiltrating15
Breast Carcinoma In Situ11
Breast Neoplasms, Male5
Inflammatory Breast Neoplasms4
Neoplasm Metastasis3
Neoplasms, Hormone-Dependent3
Carcinoma, Non-Small-Cell Lung2

Trials

Showing 26 to 46 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.